Rx Safes Discloses Unauthorized Debt Conversion H
Post# of 94141
Posted On: 01/06/2016 6:49:04 AM
Rx Safes Discloses Unauthorized Debt Conversion
HENDERSON, NV--(Marketwired - Jan 5, 2016) - Rx Safes, Inc. (OTCQB: RXSF), the developer of autonomous fingerprint healthcare security products, announced today that it was made aware this morning, by its transfer agent, that an improper and unauthorized series of debt conversions have taken place since December 24, 2015, with regard to a prior obligation of the company.
The debt conversions were not properly noticed to, nor approved by the company and the company believes that the party has submitted irregular paperwork in order to avoid notifying the company and to expedite trading over the holidays. The company has put a "stop" on all such requests by the subject party to the company's transfer agent and will contest any and all requests from said party, or its assigns. The company is prepared to take any and all legal action to protect its rights and those of its shareholders.
"I want to assure our shareholders that we do not take unauthorized debt conversions lightly. We intent to take all expedient action to prevent any further unauthorized conversions," stated the company's CEO, Ms. Lorraine Yarde. She added, "The amount of shares in question so far total less than 30,000, but based on the recent market activity, it appears that the holder jumped the gun. These shares will not be delivered until this matter is resolved to the company's satisfaction."
The current issued and outstanding shares of the company, according to the books and records of the transfer agent as of today's date is 1,467,498, and the public float is 283,025, including the shares in question.
About Rx Safes, Inc.
Rx Safes is an emerging leader in the personal and professional healthcare drug security market. Our products incorporate proprietary patented fingerprint technology to provide drug security solutions for use in homes and healthcare facilities. Prescription drug misuse, skyrocketing insurance and pharmaceutical treatment costs and increased regulatory pressures create an unfortunate, yet necessary opportunity for Rx Safes to expand our reach and offerings in this growing market, valued at over $50 billion annually. Annual spending on healthcare technology products exceeds $34.5 billion. In addition, the market is being driven by ongoing Government support for successful drug abuse prevention initiatives, with a financial commitment of $25.4 billion in 2015 alone. For more information, please visit www.rxsafes.com
HENDERSON, NV--(Marketwired - Jan 5, 2016) - Rx Safes, Inc. (OTCQB: RXSF), the developer of autonomous fingerprint healthcare security products, announced today that it was made aware this morning, by its transfer agent, that an improper and unauthorized series of debt conversions have taken place since December 24, 2015, with regard to a prior obligation of the company.
The debt conversions were not properly noticed to, nor approved by the company and the company believes that the party has submitted irregular paperwork in order to avoid notifying the company and to expedite trading over the holidays. The company has put a "stop" on all such requests by the subject party to the company's transfer agent and will contest any and all requests from said party, or its assigns. The company is prepared to take any and all legal action to protect its rights and those of its shareholders.
"I want to assure our shareholders that we do not take unauthorized debt conversions lightly. We intent to take all expedient action to prevent any further unauthorized conversions," stated the company's CEO, Ms. Lorraine Yarde. She added, "The amount of shares in question so far total less than 30,000, but based on the recent market activity, it appears that the holder jumped the gun. These shares will not be delivered until this matter is resolved to the company's satisfaction."
The current issued and outstanding shares of the company, according to the books and records of the transfer agent as of today's date is 1,467,498, and the public float is 283,025, including the shares in question.
About Rx Safes, Inc.
Rx Safes is an emerging leader in the personal and professional healthcare drug security market. Our products incorporate proprietary patented fingerprint technology to provide drug security solutions for use in homes and healthcare facilities. Prescription drug misuse, skyrocketing insurance and pharmaceutical treatment costs and increased regulatory pressures create an unfortunate, yet necessary opportunity for Rx Safes to expand our reach and offerings in this growing market, valued at over $50 billion annually. Annual spending on healthcare technology products exceeds $34.5 billion. In addition, the market is being driven by ongoing Government support for successful drug abuse prevention initiatives, with a financial commitment of $25.4 billion in 2015 alone. For more information, please visit www.rxsafes.com
(0)
(0)Scroll down for more posts ▼